Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...

This collection brings together six craft ideas with demonstrations of the making process. Each tutorial offers a different project to consider for your own creative practice. #CraftTutorials ...

Undercurrent News is trusted by seafood industry leaders worldwide for editorial content, price reporting, and data you won't find anywhere else. To read this article, sign up for a free trial below - ...

Mumbai August, 31: HEC Infra Projects Limited has received a ₹12.78 crore work order from Gujarat Energy Transmission Corporation Limited for cable and associated transmission work in the Rajkot zone, ...

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...

The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...

The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...

UAE-based residential developer HIVE has awarded a AED160 million main construction contract for its HIVE & ENTA Mina development in Ras Al Khaimah, with completion targeted for the first quarter of ...

Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...

HEC Infra Projects Ltd has won a Rs 18.67 crore order from Engineering Projects (India) Limited for EPC work at Ukai TPS. The 10-month project involves HT/LT package services for a 500 MW unit's FGD ...